Search

everythinglearnresearchcommunity

for

Search:↓

Obese women with PCOS are more likely to have fatty liver disease.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Continuing education programs significantly increased rural nurse practitioners' knowledge about PCOS.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Obesity is common in PCOS patients and early treatment is important for their heart and metabolic health.

Women with PCOS have distinct retinal changes compared to healthy women.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

PCOS affects many aspects of health, not just fertility, and needs comprehensive treatment.

Polycystic Ovary Syndrome (PCOS) is not very common among Iranian women, but it's important to prevent it because of the risk of heart disease and infertility.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Women with PCOS have worse physical health but similar mental health compared to those without PCOS.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.